| |

Home Page

Log in

Welcome to Biotechgate, your source for life science information.

Please use your username and password to log in to your account.


No account yet?

Try Biotechgate now - learn about subscription plans and pricing!

Latest News

FDA Advisory Committee Votes on Zynquista™ (sotagliflozin) as Treatment for Adults With Type 1 Diabetes
18 Jan 2019
(Nasdaq / GlobenewsWire)
Lexicon Pharmaceuticals to Host Conference Call and Webcast on January 17, 2019 to Discuss Outcome of FDA Advisory Committee Meeting for Sotagliflozin in Type 1 Diabetes
18 Jan 2019
(Nasdaq / GlobenewsWire)
Sanofi: FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatment for adults with type 1 diabetes
18 Jan 2019
(Nasdaq / GlobenewsWire)

Upcoming conferences

See Events »
Add an Event »

Latest updates

17 January 2019
Updates within the latest 30 days:
to the top ↑